A mini review of scientific and pharmacopeial requirements for the disintegration test

International Journal of Pharmaceutics

Volumn 345, Issue 1-2, 2007, Pages 2-8

  Donauer, Nina ^a   Löbenberg, Raimar ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Disintegration; ICH; Liquid filled capsules; Performance test; Pharmacopeia; Solid oral dosage forms; USP

Indexed keywords

CHEWABLE TABLET; DISINTEGRATION TEST; DRUG DOSAGE FORM; EUROPE; JAPAN; MEDICAL LITERATURE; PERFORMANCE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SCREENING TEST; UNITED STATES;

CAPSULES; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DOSAGE FORMS; EXCIPIENTS; HISTORY, 21ST CENTURY; PHARMACOPOEIAS AS TOPIC; QUALITY CONTROL; SOLUBILITY; TABLETS;

EID: 36048983389     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.08.045     Document Type: Review

References (18)

1. Cole E.T., Scott R.A., Cade D., Connor A.L., and Wilding I.R. In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules. Pharm. Res. 21 5 (2004) 793-798
2. EP, European Pharmacopeia 5.3, method 2.9.1, Council of Europe, European Directorate for the Quality of Medicines and Health Care, 2006, pp. 3351-3353.
3. Han, J.-H., Gallery, J., 2006. A risk based approach to in vitro performance testing: a case study on the use of dissolution versus disintegration for liquid filled soft gelatin capsules, American Pharmaceutical Review, September/October 2006, http://www.americanpharmaceuticalreview.com/articleDetail.asp?SID=00CAE4BA840E46AABF16E8A3E0A09CB6&ArticleID=442, accessed September 24th, 2007.
4. Honkanen O., Seppä H., Eerikäinen S., Tuominen R., and Marvola M. Bioavailability of ibuprofen form orally and rectally administered hydroxypropyl methyl cellulose capsules compared to corresponding gelatine capsules. STP Pharm. Sci. 11 (2001) 181-185
5. Honkanen O., Laaksonen P., Marvola J., Eerikäinen S., Tuominen R., and Marvola M. Bioavailability and in vitro oesophageal sticking tendency of hydroxypropyl methylcellulose capsule formulations and corresponding gelatin capsule formulations. Eur. J. Pharm. Sci. 15 (2002) 479-488
6. ICH, Q6A Decision Tree #7 online access: http://www.ich.org./LOB/media/MEDIA431.pdf, June 2007.
7. JP, Japanese Pharmacopeia XIV, chapter 14, Minister of Health, Labour and Welfare, April 2001 pp. 31-33.
8. Kamba M., Seta Y., Takeda N., Hamaura T., Kusai A., Nakane H., and Nishimura K. Measurement of agitation force in dissolution test and mechanical destructive force in disintegration test. Int. J. Pharm. 250 (2003) 99-109
9. Nagata S., Tochio S., Sakuma S., and Suzuki Y. Dissolution profiles of drugs filled into HPMC and gelatin capsules. AAPS Pharm. Sci. 3 3 (2001). (abstract) http://www.aapspharmsci.org
10. Sanderson G.R., and Clark R.C. Gellan gum, a new gelling polysaccharide. In: Phillips G.O., Wedlock D.J., and Williams P.A. (Eds). Gums and Stabilisers for the Food Industry vol. 2 (1984), Pergamon Press, Oxford 201-210
11. Tochio S., Nagata S., and Yamshita S. The influence of the composition of the test fluids on dissolution from HPMC capsules. AAPS Pharm. Sci. 4 4 (2002) (abstract W4340)
12. Tuleu C., Khela M.K., Evans D.F., Jones B.E., Nagata S., and Basit A.W. A scintigraphic investigation of the disintegration behaviour of capsules in fasting subjects: A comparison of hypromellose capsules containing carrageenan as gelling agent and standard gelatin capsules. Eur. J. Pharm. Sci. 30 (2007) 251-255
13. USP 23, 1995. United States Pharmacopeia, chapter 〈7 0 1〉, The United States Pharmacopeial Convention, Rockville, MD, pp. 1790-1791.
14. USP 23, 1998. United States Pharmacopeia, The United States Pharmacopeial Convention, Rockville, MD, Suppl. 9, pp. 4659-4660.
15. USP 26, 2003. United States Pharmacopeia, chapter 701, The United States Pharmacopeial Convention, Rockville, MD, p. 2154.
16. USP 30, 2007a. United States Pharmacopeia, chapter 〈7 0 1〉 pp. 276-277.
17. USP 30, 2007b. United States Pharmacopeia, chapter 〈2 0 4 0〉, The United States Pharmacopeial Convention, Rockville, MD, pp. 728-729
18. Wardrop J., and Ayres J.W. Bioequivalence of a novel amoxicillin/clavulanate chewable tablet formulations. Res. Commun. Pharmacol. Toxicol. 2 3 (1997) 175-191